2018
DOI: 10.1124/jpet.118.249383
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure

Abstract: In the development of antidotal therapy for treatment of organophosphate exposure from pesticides used in agriculture and nerve agents insidiously employed in terrorism, the alkylpyridinium aldoximes have received primary attention since their early development by I. B. Wilson in the 1950s. Yet these agents, by virtue of their quaternary structure, are limited in rates of crossing the blood-brain barrier, and they require administration parenterally to achieve full distribution in the body. Oximes lacking cati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
31
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(33 citation statements)
references
References 40 publications
(55 reference statements)
0
31
0
Order By: Relevance
“…Among these, RS194B (Fig. 2 , compound 4) was considered as new lead compound but turned out to be a weak reactivator of paraoxon-, sarin-, cyclosarin-, VX- and tabun-inhibited human AChE and in most cases substantially less potent compared to 2-PAM (Radic et al 2012 ; Kovarik et al 2013 ; Sit et al 2018 ). Post-exposure therapy of OP poisoned mice by RS194B (125 mg/kg) and atropine (10 mg/kg) provided good protective ratios for paraoxon, sarin and VX (unfortunately, the protective ratios of atropine alone therapy were not provided for comparison) but had no effect with soman and tabun (Radic et al 2012 ).…”
Section: Novel Reactivatorsmentioning
confidence: 99%
“…Among these, RS194B (Fig. 2 , compound 4) was considered as new lead compound but turned out to be a weak reactivator of paraoxon-, sarin-, cyclosarin-, VX- and tabun-inhibited human AChE and in most cases substantially less potent compared to 2-PAM (Radic et al 2012 ; Kovarik et al 2013 ; Sit et al 2018 ). Post-exposure therapy of OP poisoned mice by RS194B (125 mg/kg) and atropine (10 mg/kg) provided good protective ratios for paraoxon, sarin and VX (unfortunately, the protective ratios of atropine alone therapy were not provided for comparison) but had no effect with soman and tabun (Radic et al 2012 ).…”
Section: Novel Reactivatorsmentioning
confidence: 99%
“…[25][26][27][28] A zwitterionic hydroxyiminoacetamido alkylamine, RS194b, has shown efficacy in reducing AChE inhibition and attenuating the signs of toxicity elicited by sarin and paraoxon in macaques, in addition to the remediation of AChE inhibition elicited by a sarin analogue in mice. [29][30][31][32][33]…”
Section: Summary Of Research Programs Seeking a Brain-penetrating Achmentioning
confidence: 99%
“…Based on the structure of the pyridinium monoxime 2PAM (1), structures and in vitro reactivation efficacies of pyridinium aldoxime-based antidotes have evolved during seventy years of research to yield more efficient bis-pyridinium bis-oximes, such as ortho7, obidoxime or MMB4 (2)(3)(4)(5). Nevertheless, those cationic antidotes are ineffective in vivo, for reactivation of brain AChE or for reactivation of AChE in any tissue when administered orally (6), due to inability of pyridinium cations to cross biological membranes (7). Within the past decade it has become increasingly clear that for effective and complete recovery from an OP intoxication, antidotal action is needed in both peripheral and central nervous systems (8,9).…”
mentioning
confidence: 99%
“…One mechanism for antidotes to traverse biological membranes and reach the central nervous system (CNS) is by diffusion, which is most effective for uncharged molecular species when they are formed by fast equilibration with ionized species. An acetamido oxime RS194B (7) (Figure 1), is an example of an uncharged but ionizable antidote with demonstrated capacity to cross biological membranes including the blood-brain barrier (BBB) and effectively recover activity of OP inhibited AChE, both in vitro (6,7) and in vivo (7,12). Protonation states of its two ionizable groups (oxime and heterocyclic amine; both with pKa values of ~9 (7)) will equilibrate in an aqueous environment between four ionization species, cationic, anionic, zwitterionic and uncharged ( Figure 1A).…”
mentioning
confidence: 99%